Actively Recruiting
Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
Led by Yonsei University · Updated on 2026-01-21
900
Participants Needed
1
Research Sites
363 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this prospective randomized clinical trial is to compare the clinical outcomes according to the duration of aspirin and clopidogrel or prasugrel with dual anti-platelet therapy after percutaneous coronary intervention in patients with advanced chronic kidney disease using a new generation drug eluting stents.
CONDITIONS
Official Title
Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 19 years old
- Diagnosed with chronic renal failure stage IIIb, IV, or V (CKD-EPI eGFR <45 / <30 / <15 or on dialysis)
- Treated with a new generation drug eluting stent
- Signed consent form
You will not qualify if you...
- Over 85 years old
- High risk of bleeding including history of hemorrhagic stroke; stroke, dementia, or central nervous system damage within 1 year; head trauma or brain surgery within 6 months; tumor in the skull; suspected aortic dissection; internal bleeding within 6 weeks; active bleeding or bleeding disorder; major surgery, trauma, or bleeding within 3 weeks
- Need for oral anticoagulant therapy
- Pregnant women or women of childbearing age
- Life expectancy less than 1 year
- History of intracranial bleeding
- Moderate to severe hepatic impairment (Child-Pugh class B or C)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, South Korea
Actively Recruiting
Research Team
J
Jung-Sun Kim, MD, PhD, FESC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here